Isola Therapeutics Inc
CAGE Code: 890E6
NCAGE Code: 890E6
Status: Active
Type: Commercial Supplier
Summary
Isola Therapeutics Inc is an Active Commercial Supplier with the Cage Code 890E6.
Address
4408 Washburn Ave S
Minneapolis MN 55410-1534
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Gtc Service Parts Co Suburban Radiology Tonerecycle Inc. Premier Electrical Corp Aerolite Inc Engel J A Inc C J's Linen Service Non Commissioned Officers Club Chars Trench Lesage Inc Carlson Marketing Group Engineered Demolition Inc H T Electronic Laboratories Inc Os/2 Express Navarre Biomedical Ltd Johnson Larry L And Associates Inc Summit Medical Systems Inc Minnesota Absorption Corp Getchell Steel Treating Co Inc Fluidyne Engineering Corp Carlson Travel Group Inc Dba Carlson
Frequently Asked Questions (FAQ) for CAGE 890E6
- What is CAGE Code 890E6?
- 890E6 is the unique identifier used by NATO Organizations to reference the physical entity known as Isola Therapeutics Inc located at 4408 Washburn Ave S, Minneapolis MN 55410-1534, United States.
- Who is CAGE Code 890E6?
- 890E6 refers to Isola Therapeutics Inc located at 4408 Washburn Ave S, Minneapolis MN 55410-1534, United States.
- Where is CAGE Code 890E6 Located?
- CAGE Code 890E6 is located in Minneapolis, MN, USA.
Contracting History for CAGE 890E6 Most Recent 25 Records
- 75A50123C00031
- R&D For Endobronchial Lavage (Ebl) To Prevent And Treat Lung Damage From Pulmonary Chemical Agents Aoi #15: Redirect (Repurposing Drugs In Response To Chemical Threats)
- 11 Jul 2023
- R&D For Endobronchial Lavage (Ebl) To Prevent And Treat Lung Damage From Pulmonary Chemical Agents Aoi #15: Redirect (Repurposing Drugs In Response To Chemical Threats)
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75N91022C00018
- Phase I -Topic 431 - Drug Delivery By Endoesophageal Lavage (Eel) To Treat Esophageal Cancer
- 24 Aug 2022
- Phase I -Topic 431 - Drug Delivery By Endoesophageal Lavage (Eel) To Treat Esophageal Cancer
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $400,000.00
- Department Of Health And Human Services (Hhs)
- 75N91022C00018
- Phase I -Topic 431 - Drug Delivery By Endoesophageal Lavage (Eel) To Treat Esophageal Cancer
- 14 Aug 2023
- Phase I -Topic 431 - Drug Delivery By Endoesophageal Lavage (Eel) To Treat Esophageal Cancer
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $455,000.00
- Department Of Health And Human Services (Hhs)
- 75N91022C00018
- Phase I -Topic 431 - Drug Delivery By Endoesophageal Lavage (Eel) To Treat Esophageal Cancer
- 16 Feb 2023
- Phase I -Topic 431 - Drug Delivery By Endoesophageal Lavage (Eel) To Treat Esophageal Cancer
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $455,000.00
- Department Of Health And Human Services (Hhs)